glp-1 receptor agonist mechanism of action Agonists as Treatments for Type 2 Diabetes Mechanism of action for GLP-1R
Description
36-38 CURRENT GUIDELINE RECOMMENDATIONS: ROLES OF INCRETIN-BASED THERAPIES AND SGLT-2 INHIBITORS The use of currently available treatments for T2DM are guided by clinical recommendations from several organizations, including the ADA and the AACE/ACE
Di Meco A, Curtis ME, Lauretti E, Pratico D
10.1038/s42255-024-01041-8 132 YustaB.BaggioL
Your provider can evaluate your specific situation and recommend a safe transition plan to a different type of GLP-1 or an alternative strategy
Understanding personal motivations helps tailor recommendations
Statistical significance was defined as with P value of two-sided test 0.05, Fig
